Breast Radiotherapy (NCT06902311)

Name: Breast Radiotherapy trial for Breast Cancer (NCT06902311)
Uploaded: 2026-10-31T19:52:10.746Z
Duration: 1 min 19 s
Description: Breast Radiotherapy trial for Breast Cancer (NCT06902311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06902311.

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST): a one-minute explainerNCT069023111 min

Breast Radiotherapy trial for Breast Cancer (NCT06902311). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for women aged 50 or older with newly diagnosed invasive breast cancer or ductal carcinoma in situ, after breast-conserving surgery. Those needing regional lymph-node radiation cannot join.

The idea: five radiation sessions treat the whole breast and give extra radiation to the surgical cavity at the same time. Sessions occur every other day, excluding weekends. Researchers assess breast and chest-wall side effects, quality of life, and cancer control.

This phase 2 study plans 90 patients. Ethan Steele leads at UNC in Chapel Hill, the sole recruiting US site.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.